| 发明名称 | Method for inducing UDP-glucuronosyltransferase activity using pterostilbene | ||
| 摘要 | A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene. | ||
| 申请公布号 | US8841350(B2) | 申请公布日期 | 2014.09.23 |
| 申请号 | US201213466827 | 申请日期 | 2012.05.08 |
| 申请人 | ChromaDex Inc.;The Regents of the University of California | 发明人 | Bartos Jeremy;Dellinger Ryan |
| 分类号 | A61K31/09 | 主分类号 | A61K31/09 |
| 代理机构 | Amin Talati, LLC | 代理人 | Amin Talati, LLC ;Carrera, Jr. George M.;Krit Jonathan J. |
| 主权项 | 1. A method of treating an individual for actinic keratosis or dysplastic nevi, comprising administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. | ||
| 地址 | Irvine CA US | ||